Global Rofecoxib Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Rofecoxib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Rofecoxib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Osteoarthritis accounting for % of the Rofecoxib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral Suspension. segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rofecoxib include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rofecoxib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Suspension.
Tablet-Form
Market segment by Application can be divided into
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
The key market players for global Rofecoxib market are listed below:
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rofecoxib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rofecoxib, with price, sales, revenue and global market share of Rofecoxib from 2019 to 2022.
Chapter 3, the Rofecoxib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rofecoxib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rofecoxib market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rofecoxib.
Chapter 13, 14, and 15, to describe Rofecoxib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Rofecoxib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rofecoxib Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral Suspension.
1.2.3 Tablet-Form
1.3 Market Analysis by Application
1.3.1 Overview: Global Rofecoxib Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Osteoarthritis
1.3.3 Rheumatoid Arthritis
1.3.4 Juvenile Rheumatoid Arthritis
1.3.5 Acute Pain Conditions
1.3.6 Migraine
1.3.7 Dysmenorrhea
1.4 Global Rofecoxib Market Size & Forecast
1.4.1 Global Rofecoxib Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Rofecoxib Sales in Volume (2017-2028)
1.4.3 Global Rofecoxib Price (2017-2028)
1.5 Global Rofecoxib Production Capacity Analysis
1.5.1 Global Rofecoxib Total Production Capacity (2017-2028)
1.5.2 Global Rofecoxib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rofecoxib Market Drivers
1.6.2 Rofecoxib Market Restraints
1.6.3 Rofecoxib Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Rofecoxib Product and Services
2.1.4 Merck Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Chengdu Meinkai Chemical Co. LTD
2.2.1 Chengdu Meinkai Chemical Co. LTD Details
2.2.2 Chengdu Meinkai Chemical Co. LTD Major Business
2.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
2.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
2.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Details
2.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
2.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
2.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
2.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Details
2.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
2.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
2.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Rofecoxib Product and Services
2.5.4 Pfizer Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Tremeau
2.6.1 Tremeau Details
2.6.2 Tremeau Major Business
2.6.3 Tremeau Rofecoxib Product and Services
2.6.4 Tremeau Rofecoxib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Rofecoxib Breakdown Data by Manufacturer
3.1 Global Rofecoxib Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Rofecoxib Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Rofecoxib
3.4 Market Concentration Rate
3.4.1 Top 3 Rofecoxib Manufacturer Market Share in 2021
3.4.2 Top 6 Rofecoxib Manufacturer Market Share in 2021
3.5 Global Rofecoxib Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Rofecoxib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rofecoxib Market Size by Region
4.1.1 Global Rofecoxib Sales in Volume by Region (2017-2028)
4.1.2 Global Rofecoxib Revenue by Region (2017-2028)
4.2 North America Rofecoxib Revenue (2017-2028)
4.3 Europe Rofecoxib Revenue (2017-2028)
4.4 Asia-Pacific Rofecoxib Revenue (2017-2028)
4.5 South America Rofecoxib Revenue (2017-2028)
4.6 Middle East and Africa Rofecoxib Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Rofecoxib Sales in Volume by Type (2017-2028)
5.2 Global Rofecoxib Revenue by Type (2017-2028)
5.3 Global Rofecoxib Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Rofecoxib Sales in Volume by Application (2017-2028)
6.2 Global Rofecoxib Revenue by Application (2017-2028)
6.3 Global Rofecoxib Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Rofecoxib Sales by Type (2017-2028)
7.2 North America Rofecoxib Sales by Application (2017-2028)
7.3 North America Rofecoxib Market Size by Country
7.3.1 North America Rofecoxib Sales in Volume by Country (2017-2028)
7.3.2 North America Rofecoxib Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Rofecoxib Sales by Type (2017-2028)
8.2 Europe Rofecoxib Sales by Application (2017-2028)
8.3 Europe Rofecoxib Market Size by Country
8.3.1 Europe Rofecoxib Sales in Volume by Country (2017-2028)
8.3.2 Europe Rofecoxib Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Rofecoxib Sales by Type (2017-2028)
9.2 Asia-Pacific Rofecoxib Sales by Application (2017-2028)
9.3 Asia-Pacific Rofecoxib Market Size by Region
9.3.1 Asia-Pacific Rofecoxib Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Rofecoxib Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Rofecoxib Sales by Type (2017-2028)
10.2 South America Rofecoxib Sales by Application (2017-2028)
10.3 South America Rofecoxib Market Size by Country
10.3.1 South America Rofecoxib Sales in Volume by Country (2017-2028)
10.3.2 South America Rofecoxib Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rofecoxib Sales by Type (2017-2028)
11.2 Middle East & Africa Rofecoxib Sales by Application (2017-2028)
11.3 Middle East & Africa Rofecoxib Market Size by Country
11.3.1 Middle East & Africa Rofecoxib Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Rofecoxib Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Rofecoxib and Key Manufacturers
12.2 Manufacturing Costs Percentage of Rofecoxib
12.3 Rofecoxib Production Process
12.4 Rofecoxib Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Rofecoxib Typical Distributors
13.3 Rofecoxib Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Rofecoxib Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Rofecoxib Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Rofecoxib Product and Services
Table 6. Merck Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Chengdu Meinkai Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 8. Chengdu Meinkai Chemical Co. LTD Major Business
Table 9. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
Table 10. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information, Manufacturing Base and Competitors
Table 12. Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
Table 13. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
Table 14. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 16. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
Table 17. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
Table 18. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Rofecoxib Product and Services
Table 22. Pfizer Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Tremeau Basic Information, Manufacturing Base and Competitors
Table 24. Tremeau Major Business
Table 25. Tremeau Rofecoxib Product and Services
Table 26. Tremeau Rofecoxib Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Rofecoxib Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 28. Global Rofecoxib Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Rofecoxib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Rofecoxib Production Capacity by Company, (MT): 2020 VS 2021
Table 31. Head Office and Rofecoxib Production Site of Key Manufacturer
Table 32. Rofecoxib New Entrant and Capacity Expansion Plans
Table 33. Rofecoxib Mergers & Acquisitions in the Past Five Years
Table 34. Global Rofecoxib Sales by Region (2017-2022) & (MT)
Table 35. Global Rofecoxib Sales by Region (2023-2028) & (MT)
Table 36. Global Rofecoxib Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Rofecoxib Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Rofecoxib Sales by Type (2017-2022) & (MT)
Table 39. Global Rofecoxib Sales by Type (2023-2028) & (MT)
Table 40. Global Rofecoxib Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Rofecoxib Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Rofecoxib Price by Type (2017-2022) & (USD/MT)
Table 43. Global Rofecoxib Price by Type (2023-2028) & (USD/MT)
Table 44. Global Rofecoxib Sales by Application (2017-2022) & (MT)
Table 45. Global Rofecoxib Sales by Application (2023-2028) & (MT)
Table 46. Global Rofecoxib Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Rofecoxib Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Rofecoxib Price by Application (2017-2022) & (USD/MT)
Table 49. Global Rofecoxib Price by Application (2023-2028) & (USD/MT)
Table 50. North America Rofecoxib Sales by Country (2017-2022) & (MT)
Table 51. North America Rofecoxib Sales by Country (2023-2028) & (MT)
Table 52. North America Rofecoxib Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Rofecoxib Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Rofecoxib Sales by Type (2017-2022) & (MT)
Table 55. North America Rofecoxib Sales by Type (2023-2028) & (MT)
Table 56. North America Rofecoxib Sales by Application (2017-2022) & (MT)
Table 57. North America Rofecoxib Sales by Application (2023-2028) & (MT)
Table 58. Europe Rofecoxib Sales by Country (2017-2022) & (MT)
Table 59. Europe Rofecoxib Sales by Country (2023-2028) & (MT)
Table 60. Europe Rofecoxib Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Rofecoxib Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Rofecoxib Sales by Type (2017-2022) & (MT)
Table 63. Europe Rofecoxib Sales by Type (2023-2028) & (MT)
Table 64. Europe Rofecoxib Sales by Application (2017-2022) & (MT)
Table 65. Europe Rofecoxib Sales by Application (2023-2028) & (MT)
Table 66. Asia-Pacific Rofecoxib Sales by Region (2017-2022) & (MT)
Table 67. Asia-Pacific Rofecoxib Sales by Region (2023-2028) & (MT)
Table 68. Asia-Pacific Rofecoxib Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Rofecoxib Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Rofecoxib Sales by Type (2017-2022) & (MT)
Table 71. Asia-Pacific Rofecoxib Sales by Type (2023-2028) & (MT)
Table 72. Asia-Pacific Rofecoxib Sales by Application (2017-2022) & (MT)
Table 73. Asia-Pacific Rofecoxib Sales by Application (2023-2028) & (MT)
Table 74. South America Rofecoxib Sales by Country (2017-2022) & (MT)
Table 75. South America Rofecoxib Sales by Country (2023-2028) & (MT)
Table 76. South America Rofecoxib Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Rofecoxib Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Rofecoxib Sales by Type (2017-2022) & (MT)
Table 79. South America Rofecoxib Sales by Type (2023-2028) & (MT)
Table 80. South America Rofecoxib Sales by Application (2017-2022) & (MT)
Table 81. South America Rofecoxib Sales by Application (2023-2028) & (MT)
Table 82. Middle East & Africa Rofecoxib Sales by Region (2017-2022) & (MT)
Table 83. Middle East & Africa Rofecoxib Sales by Region (2023-2028) & (MT)
Table 84. Middle East & Africa Rofecoxib Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Rofecoxib Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Rofecoxib Sales by Type (2017-2022) & (MT)
Table 87. Middle East & Africa Rofecoxib Sales by Type (2023-2028) & (MT)
Table 88. Middle East & Africa Rofecoxib Sales by Application (2017-2022) & (MT)
Table 89. Middle East & Africa Rofecoxib Sales by Application (2023-2028) & (MT)
Table 90. Rofecoxib Raw Material
Table 91. Key Manufacturers of Rofecoxib Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Rofecoxib Typical Distributors
Table 95. Rofecoxib Typical Customers
List of Figures
Figure 1. Rofecoxib Picture
Figure 2. Global Rofecoxib Revenue Market Share by Type in 2021
Figure 3. Oral Suspension.
Figure 4. Tablet-Form
Figure 5. Global Rofecoxib Revenue Market Share by Application in 2021
Figure 6. Osteoarthritis
Figure 7. Rheumatoid Arthritis
Figure 8. Juvenile Rheumatoid Arthritis
Figure 9. Acute Pain Conditions
Figure 10. Migraine
Figure 11. Dysmenorrhea
Figure 12. Global Rofecoxib Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 13. Global Rofecoxib Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Rofecoxib Sales (2017-2028) & (MT)
Figure 15. Global Rofecoxib Price (2017-2028) & (USD/MT)
Figure 16. Global Rofecoxib Production Capacity (2017-2028) & (MT)
Figure 17. Global Rofecoxib Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Rofecoxib Market Drivers
Figure 19. Rofecoxib Market Restraints
Figure 20. Rofecoxib Market Trends
Figure 21. Global Rofecoxib Sales Market Share by Manufacturer in 2021
Figure 22. Global Rofecoxib Revenue Market Share by Manufacturer in 2021
Figure 23. Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Rofecoxib Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Rofecoxib Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Rofecoxib Sales Market Share by Region (2017-2028)
Figure 27. Global Rofecoxib Revenue Market Share by Region (2017-2028)
Figure 28. North America Rofecoxib Revenue (2017-2028) & (USD Million)
Figure 29. Europe Rofecoxib Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Rofecoxib Revenue (2017-2028) & (USD Million)
Figure 31. South America Rofecoxib Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Rofecoxib Revenue (2017-2028) & (USD Million)
Figure 33. Global Rofecoxib Sales Market Share by Type (2017-2028)
Figure 34. Global Rofecoxib Revenue Market Share by Type (2017-2028)
Figure 35. Global Rofecoxib Price by Type (2017-2028) & (USD/MT)
Figure 36. Global Rofecoxib Sales Market Share by Application (2017-2028)
Figure 37. Global Rofecoxib Revenue Market Share by Application (2017-2028)
Figure 38. Global Rofecoxib Price by Application (2017-2028) & (USD/MT)
Figure 39. North America Rofecoxib Sales Market Share by Type (2017-2028)
Figure 40. North America Rofecoxib Sales Market Share by Application (2017-2028)
Figure 41. North America Rofecoxib Sales Market Share by Country (2017-2028)
Figure 42. North America Rofecoxib Revenue Market Share by Country (2017-2028)
Figure 43. United States Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Rofecoxib Sales Market Share by Type (2017-2028)
Figure 47. Europe Rofecoxib Sales Market Share by Application (2017-2028)
Figure 48. Europe Rofecoxib Sales Market Share by Country (2017-2028)
Figure 49. Europe Rofecoxib Revenue Market Share by Country (2017-2028)
Figure 50. Germany Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Rofecoxib Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Rofecoxib Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Rofecoxib Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Rofecoxib Revenue Market Share by Region (2017-2028)
Figure 59. China Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Rofecoxib Sales Market Share by Type (2017-2028)
Figure 66. South America Rofecoxib Sales Market Share by Application (2017-2028)
Figure 67. South America Rofecoxib Sales Market Share by Country (2017-2028)
Figure 68. South America Rofecoxib Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Rofecoxib Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Rofecoxib Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Rofecoxib Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Rofecoxib Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Rofecoxib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Rofecoxib in 2021
Figure 80. Manufacturing Process Analysis of Rofecoxib
Figure 81. Rofecoxib Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
